# Equity Lifestyle Properties Inc: financial statements, quarterly

ELS · NYSE · CIK 895417 · [Real estate](/sectors/real-estate.md) · fiscal year ends Dec 31

Pages: [Overview](/companies/els.md) · [Financials](/companies/els/financials.md) · [Filings](/companies/els/filings.md) · [Insiders](/companies/els/insiders.md)

Standardized line items from XBRL company facts. Each value links to its filing; d marks a value derived from year-to-date figures. Other view: [annual](/companies/els/financials.md?period=annual).

## Income statement

| Line item | Unit | Q4 FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) | Q3 FY2026 (2026-09-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Revenue | $m | [361 d](/filings/0001628280-26-008722.md) | [387](/filings/0000895417-25-000040.md) | [380](/filings/0000895417-25-000069.md) | [387](/filings/0001628280-25-046869.md) | [372 d](/filings/0001628280-26-008722.md) | [387](/filings/0001628280-26-028003.md) | [377](/filings/0001628280-26-050244.md) | [393](/filings/0001628280-26-067621.md) | [374 d](/filings/0001628280-26-008722.md) | [398](/filings/0001628280-26-028003.md) | [398](/filings/0001628280-26-050244.md) | [410](/filings/0001628280-26-067621.md) |
| Gross profit | $m | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Operating income | $m | [85.4 d](/filings/0001628280-26-008722.md) | [115](/filings/0000895417-25-000040.md) | [81.5](/filings/0000895417-25-000069.md) | [82.8](/filings/0001628280-25-046869.md) | [101 d](/filings/0001628280-26-008722.md) | [109](/filings/0001628280-26-028003.md) | [84.2](/filings/0001628280-26-050244.md) | [98.1](/filings/0001628280-26-067621.md) | [100 d](/filings/0001628280-26-008722.md) | [112](/filings/0001628280-26-028003.md) | [99.4](/filings/0001628280-26-050244.md) | [101](/filings/0001628280-26-067621.md) |
| Income tax | $m | [(10.5) d](/filings/0001628280-26-008722.md) | [(0.2)](/filings/0000895417-24-000067.md) | [0.0](/filings/0000895417-24-000092.md) | [0.0](/filings/0000895417-24-000102.md) | [(0.1) d](/filings/0001628280-26-008722.md) | not reported | not reported | [(0.5)](/filings/0001628280-26-067621.md) | [(2.1) d](/filings/0001628280-26-008722.md) | not reported | not reported | [12.1](/filings/0001628280-26-067621.md) |
| Net income | $m | [96.4 d](/filings/0001628280-26-008722.md) | [115](/filings/0001628280-25-046869.md) | [82.1](/filings/0001628280-25-046869.md) | [86.9](/filings/0001628280-25-046869.md) | [101 d](/filings/0001628280-26-008722.md) | [114](/filings/0001628280-26-067621.md) | [83.5](/filings/0001628280-26-067621.md) | [100](/filings/0001628280-26-067621.md) | [104 d](/filings/0001628280-26-008722.md) | [111](/filings/0001628280-26-067621.md) | [99.5](/filings/0001628280-26-067621.md) | [89.3](/filings/0001628280-26-067621.md) |
| Diluted EPS | $ per share | not reported | [0.59](/filings/0000895417-25-000040.md) | [0.42](/filings/0000895417-25-000069.md) | [0.44](/filings/0001628280-25-046869.md) | not reported | [0.57](/filings/0001628280-26-028003.md) | [0.42](/filings/0001628280-26-050244.md) | [0.50](/filings/0001628280-26-067621.md) | not reported | [0.56](/filings/0001628280-26-028003.md) | [0.50](/filings/0001628280-26-050244.md) | [0.45](/filings/0001628280-26-067621.md) |
| Basic EPS | $ per share | not reported | [0.59](/filings/0000895417-25-000040.md) | [0.42](/filings/0000895417-25-000069.md) | [0.44](/filings/0001628280-25-046869.md) | not reported | [0.57](/filings/0001628280-26-028003.md) | [0.42](/filings/0001628280-26-050244.md) | [0.50](/filings/0001628280-26-067621.md) | not reported | [0.56](/filings/0001628280-26-028003.md) | [0.50](/filings/0001628280-26-050244.md) | [0.45](/filings/0001628280-26-067621.md) |

- Revenue: us-gaap:Revenues
- Gross profit: not reported
- Operating income: us-gaap:OperatingIncomeLoss
- Income tax: us-gaap:IncomeTaxExpenseBenefit
- Net income: us-gaap:NetIncomeLoss
- Diluted EPS: us-gaap:EarningsPerShareDiluted
- Basic EPS: us-gaap:EarningsPerShareBasic

## Balance sheet

| Line item | Unit | FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) | Q3 FY2026 (2026-09-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Cash and equivalents | $m | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Total assets | $m | [5,614](/filings/0001628280-26-008722.md) | [5,630](/filings/0000895417-25-000040.md) | [5,645](/filings/0000895417-25-000069.md) | [5,644](/filings/0001628280-25-046869.md) | [5,646](/filings/0001628280-26-008722.md) | [5,642](/filings/0001628280-26-028003.md) | [5,721](/filings/0001628280-26-050244.md) | [5,747](/filings/0001628280-26-067621.md) | [5,745](/filings/0001628280-26-067621.md) | [5,749](/filings/0001628280-26-028003.md) | [5,801](/filings/0001628280-26-050244.md) | [5,765](/filings/0001628280-26-067621.md) |
| Total liabilities | $m | [4,115](/filings/0000895417-25-000013.md) | [4,110](/filings/0000895417-24-000067.md) | [4,135](/filings/0000895417-24-000092.md) | [4,149](/filings/0000895417-24-000102.md) | [3,822](/filings/0001628280-26-008722.md) | [3,809](/filings/0000895417-25-000040.md) | [3,908](/filings/0000895417-25-000069.md) | [3,935](/filings/0001628280-25-046869.md) | [3,931](/filings/0001628280-26-067621.md) | [3,928](/filings/0001628280-26-028003.md) | [3,984](/filings/0001628280-26-050244.md) | [3,959](/filings/0001628280-26-067621.md) |
| Long-term debt | $m | [3,519](/filings/0000895417-24-000036.md) | not reported | not reported | not reported | [3,205](/filings/0000895417-25-000013.md) | not reported | not reported | not reported | [3,346](/filings/0001628280-26-008722.md) | not reported | not reported | not reported |
| Shareholders' equity | $m | [1,429](/filings/0000895417-25-000013.md) | [1,449](/filings/0000895417-24-000067.md) | [1,440](/filings/0000895417-24-000092.md) | [1,426](/filings/0000895417-24-000102.md) | [1,741](/filings/0001628280-26-008722.md) | [1,750](/filings/0000895417-25-000040.md) | [1,731](/filings/0000895417-25-000069.md) | [1,753](/filings/0001628280-25-046869.md) | [1,756](/filings/0001628280-26-067621.md) | [1,762](/filings/0001628280-26-028003.md) | [1,758](/filings/0001628280-26-050244.md) | [1,749](/filings/0001628280-26-067621.md) |

- Cash and equivalents: not reported
- Total assets: us-gaap:Assets
- Total liabilities: us-gaap:Liabilities
- Long-term debt: us-gaap:LongTermDebt
- Shareholders' equity: us-gaap:StockholdersEquity

## Cash flow

| Line item | Unit | Q4 FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) | Q3 FY2026 (2026-09-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Operating cash flow | $m | [129 d](/filings/0001628280-26-008722.md) | [199](/filings/0000895417-25-000040.md) | [143 d](/filings/0000895417-25-000069.md) | [150 d](/filings/0001628280-25-046869.md) | [105 d](/filings/0001628280-26-008722.md) | [193](/filings/0001628280-26-028003.md) | [131 d](/filings/0001628280-26-050244.md) | [147 d](/filings/0001628280-26-067621.md) | [99.5 d](/filings/0001628280-26-008722.md) | [194](/filings/0001628280-26-028003.md) | [148 d](/filings/0001628280-26-050244.md) | [152 d](/filings/0001628280-26-067621.md) |
| Capital expenditure | $m | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Dividends paid | $m | [83.4 d](/filings/0001628280-26-008722.md) | [83.4](/filings/0000895417-25-000040.md) | [89.1 d](/filings/0000895417-25-000069.md) | [89.1 d](/filings/0001628280-25-046869.md) | [89.1 d](/filings/0001628280-26-008722.md) | [91.2](/filings/0001628280-26-028003.md) | [98.4 d](/filings/0001628280-26-050244.md) | [98.5 d](/filings/0001628280-26-067621.md) | [99.8 d](/filings/0001628280-26-008722.md) | [99.8](/filings/0001628280-26-028003.md) | [105 d](/filings/0001628280-26-050244.md) | [105 d](/filings/0001628280-26-067621.md) |
| Share repurchases | $m | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |

- Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities
- Capital expenditure: not reported
- Dividends paid: us-gaap:PaymentsOfDividendsCommonStock
- Share repurchases: not reported

## Shares

| Line item | Unit | Q1 FY2023 (2023-03-31) | Q2 FY2023 (2023-06-30) | Q3 FY2023 (2023-09-30) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) | Q3 FY2026 (2026-09-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Diluted shares (weighted) | millions of shares | [195](/filings/0000895417-24-000067.md) | [195](/filings/0000895417-24-000092.md) | [195](/filings/0000895417-24-000102.md) | [196](/filings/0000895417-25-000040.md) | [195](/filings/0000895417-25-000069.md) | [196](/filings/0001628280-25-046869.md) | [200](/filings/0001628280-26-028003.md) | [200](/filings/0001628280-26-050244.md) | [200](/filings/0001628280-26-067621.md) | [200](/filings/0001628280-26-028003.md) | [200](/filings/0001628280-26-050244.md) | [200](/filings/0001628280-26-067621.md) |

- Diluted shares (weighted): us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding

Shares outstanding: 194,785,616 at 2026-10-21, from the cover of the [10-Q filed 2026-10-27](/filings/0001628280-26-067621.md) (dei:EntityCommonStockSharesOutstanding).

Source: SEC EDGAR, XBRL company facts. Last ingested by Listed: Oct 27, 2026, 21:28 ET. No prices; not investment advice.